Tumor Mutational Burden: A Continually Evolving Biomarker for Immunotherapy

Dan Brudzewsky, PhD Senior Field Applications Scientist - UK & Nordics Travis Yates, PhD Field Applications Scientist Tumor Mutational Burden: A Continually Evolving Biomarker for Immunotherapy Within recent years, the field of oncology has seen major advancements in regards to therapeutic options for patients. Immunotherapy, which relies on [...]